BWX Technologies, Inc. (NYSE:BWXT) Receives Average Recommendation of “Moderate Buy” from Brokerages

BWX Technologies, Inc. (NYSE:BWXT) has received a consensus rating of “Moderate Buy” from the fifteen ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, eight have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $228.00.

Several equities research analysts have recently weighed in on BWXT shares. Seaport Research Partners raised BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 target price on the stock in a research report on Monday, June 22nd. Wall Street Zen raised shares of BWX Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Deutsche Bank Aktiengesellschaft upgraded shares of BWX Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $205.00 to $255.00 in a research report on Friday, May 15th. Zacks Research downgraded shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Finally, Truist Financial lifted their price target on shares of BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a research note on Monday, May 11th.

BWX Technologies Stock Down 4.7%

BWX Technologies stock opened at $177.32 on Tuesday. BWX Technologies has a 1-year low of $136.18 and a 1-year high of $241.82. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. The stock has a market cap of $16.24 billion, a PE ratio of 47.41, a P/E/G ratio of 3.17 and a beta of 0.74. The stock’s fifty day moving average is $197.55 and its two-hundred day moving average is $203.04.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. The company had revenue of $860.22 million during the quarter, compared to the consensus estimate of $837.47 million. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.BWX Technologies’s revenue for the quarter was up 26.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 EPS. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, sell-side analysts expect that BWX Technologies will post 4.6 EPS for the current fiscal year.

BWX Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Shareholders of record on Tuesday, May 19th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Tuesday, May 19th. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio (DPR) is presently 28.88%.

Insider Transactions at BWX Technologies

In other news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the sale, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at approximately $1,440,477. The trade was a 25.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the sale, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at approximately $41,472,181.71. This trade represents a 4.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On BWX Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in BWX Technologies during the 4th quarter worth $9,754,000. Massachusetts Financial Services Co. MA boosted its stake in shares of BWX Technologies by 18.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,375,740 shares of the technology company’s stock worth $237,783,000 after buying an additional 216,707 shares during the period. MGO One Seven LLC grew its holdings in shares of BWX Technologies by 354.7% during the fourth quarter. MGO One Seven LLC now owns 17,695 shares of the technology company’s stock worth $3,058,000 after buying an additional 13,803 shares during the last quarter. Granahan Investment Management LLC purchased a new stake in BWX Technologies during the 3rd quarter valued at approximately $1,941,000. Finally, Intech Investment Management LLC lifted its position in BWX Technologies by 22.7% during the 4th quarter. Intech Investment Management LLC now owns 32,668 shares of the technology company’s stock worth $5,646,000 after acquiring an additional 6,053 shares during the period. Hedge funds and other institutional investors own 94.39% of the company’s stock.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.